MCI Onehealth Provides Corporate Update - Seite 2

The Corporation’s privately paid for services have expanded greatly within recent months, including through MCI Onehealth’s successful engagements by corporate clients in the transportation, manufacturing and healthcare sectors during the quarter. Revenue from privately paid for health services accelerated during the fourth quarter to drive growth in excess of 120% for the full year ended December 31, 2020 from this higher margin offering. The increasing utilization of privately insured services highlights the increasing adoption of a profitable revenue stream and expansion of MCI Onehealth's presence within the larger corporate health market. 

In furtherance of one of the Corporation’s key growth initiatives, the Corporation has identified a number of potential acquisition targets and is pursuing a number of accretive acquisitions. These and other acquisitions will support the Corporation’s dedication to developing a pipeline of opportunities for sustained expansion.

Through the forgoing efforts, the Corporation is creating a more extensive and complete service offering and expanding the opportunity for de-identified data commercialization through both clinical and commercial applications. With over two million accessible patient records already, MCI Onehealth is committed to growing what will eventually be one of the largest de-identified and actionable primary care databases in Canada to empower physicians and put patients’ health first.

Entering 2021, the Corporation is very well positioned to achieve its objective of generating revenue through three primary sources:

• Traditional government funded healthcare services driven by patient visits and government reimbursements from the Company’s brick and mortar clinics and telehealth/virtual care consultations.
• Privately funded healthcare services such as occupational health for corporate customers and corporate benefits that are outside of the scope of government funding programs but fulfilled by MCI Onehealth employees and third party contractors at the customer’s site, the Corporation’s brick and mortar clinics or via telehealth/virtual care consultations.
• Technology solutions including commercializing opportunities utilizing  de-identified data insights, as well as patient and physician facing applications. Potential purchasers of these insights and solutions include life sciences companies, medical device companies, academic institutions and diagnostics companies.